Galevant Institute: All members}

Tolgaexope

Fri, 30 Jan 2026 08:15:42 -0500

Per Stålhandske

Fri, 14 Mar 2025 09:46:06 -0400

Per is an emeritus cancer researcher and molecular biologist. He has a diverse career spanning academic research, industrial development, and quality management. He holds a PhD in Medical Genetics from Uppsala University.

Per has served as a Senior Scientist and Quality Assurance (QA) Manager at companies such as Oasmia Pharmaceutical and Sangtec Medical. He was the Co-Founder and first CEO of cSens AB, a company focused on unique technical concepts for diagnostic oncology products. In 2016, cSens merged with Biovica International AB.

For the Galevant Institute Per serves as an expert advisor on science and technology within the oncology domain.

Marcus Söderström

Sun, 26 Jan 2025 13:13:07 -0500

Marcus is a medicinal chemist and a licensed pharmacist. His work primarily focuses on the development of synthetic methods for drug discovery and the study of molecular interactions. Adressing the unmet need to treat Alzheimer’s disease and finding new targeted modalities for cancer medicine are examples of his current work. At Uppsala University Marcus is a reseacher and postdoc at the Department of Medicinal Chemistry. Since 2024 he also holds the position of Beijer Researcher at the Beijer Laboratory for Pharmaceutical Research.

Marcus is the primary liason between the Galvant Institute and Uppsala University and he is a key contributor to the TrebC project.

Mikael Franzén

Sat, 25 Jan 2025 00:54:52 -0500

I’m intrigued about life and the world - And, I’m trying to find ways to make the most out of this journey.
Logic and intuition should in my opinion go hand in hand. Emotion and rationality are not in-and-of-themselves opposites.

Will add more info soon…